2005/2006 Pharmaceutical R&D Statistical Sourcebook Provides the Latest Intelligence on Every Aspect of Pharmaceutical Development
Posted on: Thursday, 9 March 2006, 12:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c34104) has announced the addition of Pharmaceutical R&D Statistical Sourcebook 2005/2006 to their offering.
Now industry's most widely read reference on emerging pharma/biotech R&D trends, this Pharmaceutical R&D Statistical Sourcebook 2005/2006 features hundreds of pages of all-new, real-world studies, analyses, articles, and data sets providing fresh insights into the developments reshaping pharma R&D and the industry itself.
Supported by thousands of graphs, illustrations, and analyses, the Pharmaceutical R&D Statistical Sourcebook provides the latest intelligence on every aspect of pharmaceutical development--from product discovery to R&D performance and productivity to time-to-market trends.
An invaluable resource for executives and professionals working within or with the pharma and biotech industries, this 2005/2006 compendium puts real-world data sets at your fingertips for presentations, reports, business development efforts, meetings, and critical decision-making analyses.
From advances in clinical trial simulation and genomics to emerging trends in industry's product pipeline to the new demographics of US clinical investigators, make sure that your meetings, reports, presentations, and decision-making are based on the very best and latest data available today! Leading Pharmaceutical Company R&D Profiles: GlaxoSmithKline Biogen Idec Pfizer AstraZeneca Roche Amgen Schering-Plough Merck Bayer Sanofi-Synthelabo Abbott Laboratories Eli Lilly and Company Wyeth Novartis Aventis Bristol-Myers Squibb Johnson & Johnson Development Project Pipelines for Selected Other Pharma Companies by Therapeutic Category Sankyo Chugai Novo Nordisk Schering AG Dainippon Watson Yamanouchi Mylan/Bertek Takeda Daiichi Eisai
For more information visit http://www.researchandmarkets.com/reports/c34104
Source: Business Wire
Related Articles
- Research and Markets: North America Pharmaceuticals Sectors: A Company and Industry Analysis (July 2008) - in 2007, Total Drugs Spending in Canada Totalled C$27 Billion (US$26.75 Billion)
- Hollis-Eden Pharmaceuticals Reports Positive Preliminary Data From Ongoing Phase I/II Clinical Trial With TRIOLEX(TM) in Obese Insulin Resistant Subjects
- Research and Markets: Gas Supply Utilities and Industries of the World Report Ed. 8 (2006) & Gas Companies Database Ed. 2 (2006) Report Package
- Examine Global Trends in the Pharmaceutical Industry - Pharmaceuticals - Global Outlook 2006
- BioSante Pharmaceuticals Reports Product Development Highlights and Financial Results for 2005
- Webco Industries, Inc. Reports Fiscal 2006 First Quarter Results
- CollaGenex Pharmaceuticals Reports Financial Results For the Third Quarter of 2005
- MAIR Holdings, Inc. Reports Fiscal 2006 First Quarter Results
- CollaGenex Pharmaceuticals Reports Financial Results for the Second Quarter of 2005
- Research and Markets: Healthcare Trends & Forecasts in 2005: Performance Expectations for the Healthcare Industry
 |
 |
User Comments (0)
RSS Feeds